Agilent Technologies (A) Stock Insights
A$175.34—
Market cap$48.04BEnterprise value—Revenue (TTM)$7.37BMarket positionTop 25%
Score
43
Bearish
Value
22
Quality
62
Growth
45
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2011 | Life Sciences and Applied Markets: 1792000000.0 |
| FY2012 | Chemical Analysis: 1559000000.0, Diagnostics and Genomics: 402000000.0, Electronic Measurement: 3315000000.0, Life Sciences and Applied Markets: 1582000000.0 |
| FY2013 | Chemical Analysis: 1594000000.0, Electronic Measurement: 2888000000.0, Life Sciences and Applied Markets: 2300000000.0 |
| FY2014 | Chemical Analysis: 1676000000.0, Electronic Measurement: 2933000000.0, Life Sciences and Applied Markets: 2372000000.0 |
| FY2015 | Diagnostics and Genomics: 662000000.0 |
| FY2016 | Agilent CrossLab: 1420000000.0, Diagnostics and Genomics: 709000000.0, Life Sciences and Applied Markets: 2073000000.0 |
| FY2017 | Agilent CrossLab: 1531000000.0, Diagnostics and Genomics: 772000000.0, Life Sciences and Applied Markets: 2169000000.0 |
| FY2018 | Agilent CrossLab: 1701000000.0, Diagnostics and Genomics: 943000000.0, Life Sciences and Applied Markets: 2270000000.0 |
| FY2019 | Agilent CrossLab: 1840000000.0, Diagnostics and Genomics: 1021000000.0, Life Sciences and Applied Markets: 2302000000.0 |
| FY2020 | Agilent CrossLab: 1900000000.0, Diagnostics and Genomics: 1047000000.0, Life Sciences and Applied Markets: 2392000000.0 |
| FY2021 | Agilent CrossLab: 2200000000.0, Diagnostics and Genomics: 1296000000.0, Life Sciences and Applied Markets: 2823000000.0 |
| FY2022 | Agilent CrossLab: 1452000000.0, Diagnostics and Genomics: 1389000000.0, Life Sciences and Applied Markets: 4007000000.0 |
| FY2023 | Agilent CrossLab: 1568000000.0, Diagnostics and Genomics: 1409000000.0, Life Sciences and Applied Markets: 3856000000.0 |
| FY2024 | Agilent CrossLab: 1644000000.0, Diagnostics and Genomics: 1651000000.0, Life Sciences and Applied Markets: 3215000000.0 |
| FY2025 | Agilent CrossLab: 2908000000.0, Applied Markets: 1314000000.0, Life Sciences and Applied Markets: 2726000000.0 |
| Period | Value |
|---|---|
| FY2010 | Americas: 1760000000.0, CHINA: 744000000.0, Japan: 549000000.0, Rest Of World: 2391000000.0 |
| FY2011 | Americas: 2016000000.0, CHINA: 1035000000.0, Japan: 700000000.0, Rest Of World: 2864000000.0 |
| FY2012 | Americas: 2218000000.0, CHINA: 1078000000.0, Japan: 716000000.0, Rest Of World: 2846000000.0 |
| FY2013 | Americas: 2043000000.0, CHINA: 1131000000.0, Japan: 628000000.0, Rest Of World: 2980000000.0 |
| FY2014 | Americas: 2070000000.0, CHINA: 1133000000.0, Japan: 595000000.0, Rest Of World: 3183000000.0 |
| FY2015 | Americas: 1206000000.0, CHINA: 633000000.0, Rest Of World: 2199000000.0 |
| FY2016 | Americas: 1251000000.0, CHINA: 821000000.0, Rest Of World: 2130000000.0 |
| FY2017 | Americas: 1314000000.0, CHINA: 900000000.0, Rest Of World: 2258000000.0 |
| FY2018 | Americas: 1414000000.0, CHINA: 1015000000.0, Rest Of World: 2485000000.0 |
| FY2019 | Americas: 1861000000.0, Asia Pacific: 1861000000.0, Europe: 1441000000.0 |
| FY2020 | Americas: 1968000000.0, Asia Pacific: 1928000000.0, Europe: 1443000000.0 |
| FY2021 | Americas: 2404000000.0, Asia Pacific: 2227000000.0, Europe: 1688000000.0 |
| FY2022 | Americas: 2682000000.0, Asia Pacific: 2467000000.0, Europe: 1699000000.0 |
| FY2023 | Americas: 2732000000.0, Asia Pacific: 2347000000.0, Europe: 1754000000.0 |
| FY2024 | Americas: 2573000000.0, Asia Pacific: 2167000000.0, Europe: 1770000000.0 |
| FY2025 | Americas: 2806000000.0, Asia Pacific: 2219000000.0, Europe: 1923000000.0 |